In the evolving field of biochemical research, the study of synthetic ligands has provided scientists with invaluable tools to map complex physiological pathways. Among these, DAMGO peptide stands out as a foundational compound for those investigating the dynamics of receptor-ligand interactions. As a researcher and enthusiast of peptide science, I have found that understanding the technical specifications of such compounds is essential for appreciating their role in modern experimental landscapes.
What is DAMGO?
At its core, DAMGO is a synthetic opioid peptide that has become a staple in laboratory settings. Often refer Enhanced brain delivery of the opioid peptide DAMGO in red to by its synonym, DAGO, or by the chemical descriptor [D-Ala2, N-Me-Phe4, Gly-ol5]-enkephalin, it is essentially a modified, stable version of the naturally occurring enkephalin peptides.
From a structural perspective, DAMGO is a synthetic analogue of the endogenous enkephalin peptides, engineered to resist enzymatic degradation. This increased stability is why it is preferred in long-duration studies. With a molecular weight of 513.70 Da and a chemical formula of C26H35N5O6, it serves as a high-purity reference material for those working with G protein-coupled receptors.
Mechanism and Selectivity
The primary utility of this compound lies in its precision. DAMGO is a highly selective peptide agonist for the μ-opioid receptor (MOR). In scientific literature, it is frequently cited for its high affinity, with a Kd of 3.46 nM for the DAMGO is a highly selective peptide agonistfor the μ-opioid receptor (MOR) with a Kd of 3.46nM[1-2]. DAMGO activates G protein-coupled receptors, Read more native receptor. Because DAMGO is a highly selective peptide agonist, it allows researchers to isolate the activity of the μ-opioid receptor from other receptor types, such as the δ or κ receptors.
This level of specificity is why it is widely categorized as a synthetic compound that acts as a highly selective agonist for the mu opioid receptor. By utilizing this agent, laboratories can perform high-resolution mapping of neural signaling pathways without the "noise" of non-specific receptor binding.
Key Considerations in Research Applications
When reviewing the data on opioid peptide DAMGO, several technical observations emerge regarding its behavior in biological systems:
* Blood-Brain Barrier (BBB) Challenges: A significant area of study involves attempts to enhance and prolong blood-to-brain drug delivery of the molecule. Because it is a hydrophilic peptide, it faces inherent challenges in crossing the BBB, leading researchers to explore carrier systems like GSH-PEG liposomes to optimize its distribution.
* Neurological and Behavioral Influence: Studies have noted that DAMGO suppresses activity in rNST neurons and can affect locomotive activity in rodent models. These obser Enhanced Brain Delivery of the Opioid Peptide DAMGO in vations are crucial for understanding how receptor activation influences systemic responses.
* Systemic Observations: It is well-documented in preclinical literature that DAMGO can slow down the movement of the intestines, a common physiological observation DAMGO | Opioid Receptor when studying μ-opioid receptor agonists in laboratory models.
Emerging Trends: Hybrid Peptides
The scientific community is not stagnant. Recent advancements have led to the development of five new hybrid EM2/DAMGO analogues. By combining the structural benefits of endomorphin-2 (EM2) with the stability of DAMGO, researchers are aiming to create molecules with even higher specificity and more favorable pharmacokinetic profiles. This hybrid approach represents the cutting edge of peptide design, moving beyond single-molecule agonists to more complex, multi-functional structures.
Personal Perspective on Peptide Science
From my own experience following the literature, the transition from simple endogenous molecules to sophisticated tools like DAMGO highlights the power of synthetic chemistry. It is fascinating to see how a small modification—turning a native enkephalin into a stable synthetic peptide μ-opioid receptor agonis DAMGO is a μ-opioid receptor (μ-OPR ) selective agonistwith a Kd of 3.46 nM for native μ-OPR. - >99% HPLC purity, ideal for cancer research and epigenetic t (μOR)—can unlock so much potential for understanding cellular communication.
Whether it is being used to probe the structure of the human μOR-G protein complex or to investigate the nuances of biased signaling, the compound class: peptide continues to b The IUPHAR/BPS Guide to Pharmacology.DAMGO ligand page Compound class: Peptide. Click here for help. Ligand Activity Visualisation Read more e a cornerstone of modern biochemistry. For anyone looki DAMGO is a μ-opioid receptor (μ-OPR ) selective agonistwith a Kd of 3.46 nM for native μ-OPR. - >99% HPLC purity, ideal for cancer research and epigenetic ng into the technical aspects of DAMGO, mu opioid receptor agonist, the key takeaway remains the same: it is a high-purity tool that, when used correctly in a controlled environment, provides unparalleled clarity into the me DAMGO is a highly selective peptide agonistfor the μ-opioid receptor (MOR) with a Kd of 3.46nM[1-2]. DAMGO activates G protein-coupled receptors, Read more chanisms of receptor activation.
***
*Disclaimer: This article is for informational and educational purposes based on existing scientific literature. It does not constitute medical, health, or safety advice. The substances discussed are strictly for laboratory The μ-opioid receptor agonist DAMGO presynaptically research use only and are not intended for human or animal consumption.*